Citation: | GAN Jing, ZHANG Xin-zhi, WU Yan-sheng, XU Li, LU Li-li, GAO Jian-dong. Investigation and analysis of anemia incidence in patients with polycystic kidney disease[J]. Journal of Clinical Nephrology, 2020, 20(3): 203-206. DOI: 10.3969/j.issn.1671-2390.2020.03.006 |
[1] |
Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease[J]. Lancet, 2019, 393(10174):919-935. DOI: 10.1016/S0140-6736(18)32782-X.
|
[2] |
陈欢欢. 200例成人型多囊肾病患者临床特征分析及中医证候研究[D].广州:广州中医药大学, 2016.
|
[3] |
Racki S, Maleta I. Role of renal anemia in progression of chronic kidney disease[J]. Acta Med Croatica, 2009, 63, Suppl 1(6):33-37.
|
[4] |
Czarnecki PG, Steinman TI. Polycystic kidney disease:new horizons and therapeutic frontiers[J].Italian J Urol Nephrol, 2013, 65(1):61-68.DOI: 10.1038/aja.2012.129.
|
[5] |
Alam A, Perrone RD. Management of ESRD in patients with autosomal dominant polycystic kidney disease[J]. AdvChronic Kidney Dis, 2010, 17(2):164-172. DOI: 10.1053/j.ackd.2009.12.006.
|
[6] |
黎磊石,刘志红.中国肾脏病学[M].北京:人民军医出版社, 2008:1018.
|
[7] |
Riella MC. Kidney disease:Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease[J]. Kidney International Supplements, 2013, 3(1):1-150.DOI: 10.1038/kisup.2012.73.
|
[8] |
Mcdonald RA.KDIGO clinical practice guideline for anemia in chronic kidney disease[J]. Kidney International Supplements, 2012, 2(4):279-335.DOI: 10.1038/kisup.2012.1.
|
[9] |
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009,150(9):604-612. DOI: 10.7326/0003-4819-150-9-200905050-00006.
|
[10] |
施善芬,黎良达,潘翠萍,等.常染色体显性遗传多囊肾病患者贫血情况分析[J].中国医刊, 2013, 48(3):62-63. DOI: 10.3969/j.issn.1008-1070.2013.03.022.
|
[11] |
李静.浅析进行血液透析的患者发生失血的原因及对策[J].当代医药论丛, 2017, 15(16):269-271. DOI: 10.3969/j.issn.2095-7629.2017.16.197.
|
[12] |
Tozoni SS, Dias GF, Bohnen G, et al. Uremia and hypoxia independently induce eryptosis and erythrocyte redox imbalance[J]. Cell PhysiolBiochem, 2019, 53:794-804. DOI: 10.33594/000000173.
|
[13] |
Awan AA, Walther CP, Richardson PA, et al. Prevalence, correlates and outcomes of absolute and functional iron deficiency Anemia in nondialysis-dependent chronic kidney disease[J].Nephrol Dial Transplant, 2019:gfz192. DOI: 10.1093/ndt/gfz192.
|
[14] |
Yeh SC, Lin YC, Hong YC, et al. Different effects of iron indices on mortality in patients with autosomal dominant polycystic kidney disease after long-term hemodialysis:anationwide population-based study[J]. J Ren Nutr, 2019, 29(5):444-453. DOI: 10.1053/j.jrn.2018.11.004.
|
[15] |
Hatamizadeh P, Ravel V, Lukowsky LR, et al. Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease[J].Nephrol Dial Transplant, 2013, 28(11):2889-2898. DOI: 10.1093/ndt/gft411.
|
[16] |
王艳丽.慢性肾脏病患者贫血现况的调查及其分析[J].湖北中医杂志, 2016, 38(5):16-18.
|